TREX WIND-DOWN, INC.: Nasdaq/NYSE listing notice — Timber Pharma receives NYSE American delisting notice for stockholders' deficit of $1.3M

TREX WIND-DOWN, INC.

Stockholders' deficit of $1.3M as of March 31, 2023 triggers non-compliance with Sections 1003(a)(i) and (ii).
Company must submit compliance plan by July 28, 2023; deadline to regain compliance is December 28, 2024.
Common stock (TMBR) continues trading but with added '.BC' designation for below compliance.
Failure to submit or execute plan may lead to delisting, reducing liquidity and financing options.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

TREX WIND-DOWN, INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(i), 1003(a)(ii)

Exact text from the filing

June 28, 2023, Timber Pharmaceuticals, Inc. (the “ Company ”) received a deficiency letter (the “ Deficiency Letter ”) from the NYSE American LLC (the “ NYSE American ”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. Section 1003(a)(i) of the NYSE American Company Guide requires a listed company’s stockholders’ equity be at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. Section

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001437749-23-019229

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.